The Generalizability of NCI-sponsored Clinical Trials Accrual Amongst Women With Gynecologic Malignancies

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2016.04.065
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic and Predictive Factors Associated With Ipilimumab-Related Adverse Events: A Retrospective Analysis of 11 NCI-sponsored Phase I Clinical Trials

Oncotarget
Oncology
2020English

Identification of Accrual Barriers Onto Breast Cancer Prevention Clinical Trials

Cancer
Cancer ResearchOncology
2010English

An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2004English

Gynecologic Malignancies Post-LeFort Colpocleisis

Case Reports in Obstetrics and Gynecology
2014English

Physician Remuneration in Industry-Sponsored Clinical Trials: The Case for Standardized Clinical Trial Budgets

CMAJ
Medicine
2004English

Total Pelvic Exenteration for Gynecologic Malignancies

International Journal of Surgical Oncology
SurgeryOncology
2012English

Postoperative Acute Kidney Injury in Patients With Gynecologic Malignancies

Critical Care
Critical CareIntensive Care Medicine
2014English

Mannose-Binding Lectin Codon 54 Genetic Polymorphism and Vaginal Protein Levels in Women With Gynecologic Malignancies

European Journal of Obstetrics, Gynecology and Reproductive Biology
GynecologyReproductive MedicineObstetrics
2012English

New Agreement Aims to Streamline Sponsored Clinical Trials in NHS

BMJ
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy